Silverarc Capital Management »

Sarepta Therapeutics shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.1M 9.2k 121.22
2023-06-30 $3.4M 30k 114.52
2023-03-31 $1.3M 9.3k 137.83

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Sarepta Therapeutics

Vanguard Group
BlackRock
Henderson Group
venBio Select Advisor
Wellington Management Company
Farallon Capital Management
Citadel Advisors
Bank of New York Mellon
T. Rowe Price Investment Management
EcoR1 Capital
Jpmorgan Chase & Co
Logos Global Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
FMR

View all funds holding Sarepta Therapeutics